Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 17/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16776307 | 0.93 | CNR2 (0.36) | SLC5A1CNR2TRPV1SCN9A | |
| SCHEMBL16776387 | 0.83 | PTGS1 (0.35) | CNR2TRPV1 | |
| SCHEMBL16776391 | 0.79 | SLC5A1 (0.34) | SLC5A1 | |
| SCHEMBL16785563 | 0.79 | TRPA1 (0.33) | SLC5A1 | |
| SCHEMBL16785537 | 0.79 | SCN9A (0.39) | SLC5A1CNR2TRPV1SCN9A | |
| SCHEMBL16776478 | 0.79 | SCN9A (0.39) | SLC5A1CNR2TRPV1SCN9A | |
| SCHEMBL16785562 | 0.78 | RPS6KA3 (0.38) | TRPV1 | |
| SCHEMBL16776393 | 0.76 | AR (0.34) | — | |
| SCHEMBL16776376 | 0.75 | POLB (0.41) | CNR2 | |
| SCHEMBL16776377 | 0.75 | MPL (0.41) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150152108-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152108-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | SIRT1, SIRT3, SIRT2 | SLC5A1 1202/4885CNR2 2514/4885TRPV1 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.